|
1 Hoey T, Gruaby MJ. STAT3 as mediation of cytokine-induced response[J]. Adv Immunity, 1998, 71: 145-160.
|
|
2 Calo V, Migliavacca M, Bazan V, et al. STAT Proteins: From normal control of ellular events to tumorigenesis[J]. J Cell Physiol, 2003, 197(2): 157-168.
|
|
3 Petterino C, Podestà G, Ratto A, et al. Immunohistochemical study of phospho-Stat3-ser727 expression in feline mammary gland tumours[J]. Vet Res Commun, 2007, 31(2): 173-184.
|
|
4 Zuyao Ni, Wei Lou, Eddy SL, et al. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells [J]. Cancer Res, 2003, 60(1): 1225-1228.
|
|
5 Lutticken C, Wegenka UM, Yuan J, et al. Association of transcription factor APRF and protein kinase JAK 1 with IL-6 signal transducer gpl30[J]. Science, 1994, 263(5143): 89-92.
|
|
6 Suganuma M, Okabe S, Kurusu M, et al. Discrete roles of cytokines, TNF-alpha, IL-1, IL-6 in tumor promotion and cell transformation[J]. Int J Oncol, 2002, 20(1): 131-136.
|
|
7 Aziz N, Cherwinski H, McMahon M, et al. Complementation of defective colony-stimulating factor I receptor signaling and mitogenesis by raf and v-Src[J]. Mol Cell Biod, 1999, 19(2): 1101-1115.
|
|
8 Quintanilla-Martinez L, Kremer M, Specht K, et al. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events[J]. Am J Pathol, 2003, 162(5): 1449-1461.
|
|
9 Wagner M, Siddiqui MA. Signaling networks regulating cardiac myocytesurvival and death[J]. Curr Opin Investig Drugs, 2009, 10(9): 928-937.
|
|
10 Dreyling MH, Bullinger L, Ott G, et al. Alterations of the cyclinD1/P16.pRb pathway in mantle cell lymphoma[J]. Cancer Res, 1997, 57(20): 4608-4614.
|
|
11 Aaronson DS, Horvath CM. A road map for those who don't know JAK-STAT[J]. Science, 2003, 29(6): 1653-1655.
|
|
12 Burkea WM, Jin X, Lin H, et al. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells[J]. Oncogene, 2001, 20(55): 7925-7934.
|
|
13 Selvendiran K, Koga H, Ueno T, et al. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: An implication for the antitumor potential of flavonoids[J]. Cancer Res, 2006, 66(9): 4826-4834.
|
|
14 Tomida M, Ohtake H, Yokata T, et al. Stat3 up-regulates expression of nicotinamide N -methyltransferase in human cancer cell[J]. J Cancer Res Clin Oncol, 2008, 134(5): 551-557.
|
|
15 Allen D, Kenna PF, Palfi A, et al. Development of strategies for conditional RNA interference[J]. J Gene Med, 2007, 9(4): 287-298.
|
|
16 Nishimoto A, Yu Y, Lu Z, et al. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells[J]. Cancer Res, 2005, 65(15): 6701-6710.
|
|
17 Pathak AK, Bhutani M, Nair AS, et al. Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells[J]. Mol Cancer Res, 2007, 5(9): 943-955.
|
|
18 Kotha A, Sekharam M, Cilenti L, et al. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein[J]. Mol Cancer Ther, 2006, 5(3): 621-629.
|
|
19 Daniel GR, Imelda MU, Gong Y, et al. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis[J]. Cancer, 2006, 107(11): 2730-2740.
|
|
20 Huang M, Page C, Reynolds RK, et al. Constitutive activation of stat 3 oncogene product in human ovarian calinonla cells[J]. Gynecol Oncol, 2000, 79(1): 67-73.
|
|
21 Yamamotos, Konishi Z, Kuroda H, et al. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Cot-relation with clinicopathology and patient survival, and analysis serum VEGF levels[J]. Br J Cancer, 1997, 76(9): 1221-1227.
|
|
22 Chen BY, Ye DF, Xie X, et al. Expressions of VEGF/VEGFRs and activation of STATs in ovarian carcinoma[J]．China J Oncol, 2005, 27(1): 33-37. [陈冰亚，叶大风，谢幸，等．卵巢上皮癌细胞中VEGF和VEGFRs的表达与STATs的活化[J]．中华肿瘤杂志，2005, 27(1): 33-37.]
|
|
23 Wei D, Le X, Zheng L, et al. STA3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis[J]. Oncogene, 2003, 22: 319.
|
|
24 Silver DL, Naora H, Liu J, et al. Activated signal transducer and activator of transcription (STAT) 3: Localization in focal adhesions and function in ovarian cancer cell motility[J]. Cancer Res, 2004, 64(15): 3550-3558.
|
|
25 Page C, Huang M, Jin X, et al. Elevated phosphory1ation of AKT and Stat3 in prostate, breast, and cervical cancer cells[J]. Int J Oncol, 2000, 17(1): 23-28.
|
|
26 Chen CL, Hsieh FC, Lieblein JC, et al. STAT3 activation in human endometrial and cervical cancers[J]. Br J Cancer, 2007, 96(4): 591-599.
|
|
27 Niu G, Wright KL, Huang M, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis[J]. Oncogene, 2002, 21(13): 2000-2008.
|
|
28 Yang SF, Yuan SS, Yeh YT, et al. Positive association between STAT3 and Ki-67 in cervical intraepithelial neoplasiar[J]. Kaohsiung J Med Sci, 2006, 22(11): 539-546.
|
|
29 Takemoto S, Ushijima K, Kawano K, et al. Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma[J]. Br J Cancer, 2009, 101: 967-972.
|
|
30 Catalano S, Giordano C, Rizza P, et al. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation[J]. J Cell Physiol, 2009, 18(3): 490-500.
|
|
31 Gao J, Tian J, Lv Y, et al. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells[J]. Cancer Sci, 2009, 100(3): 389-395.
|